Posts

BMS Terminates Two Mid-Stage and Four Early-Stage Clini...

During an R&D Day presentation, Bristol Myers Squibb (BMS) made significant alte...

Kroger Health Joins Hands With Performance Kitchen to P...

Kroger Health, a division of the Kroger Company, has partnered with Performance ...

Blackstone’s $250 million investment in ex-Novartis ass...

Blackstone Life Sciences’ substantial $250 million investment in Anthos Therapeu...

BioNTech receives $90 million from CEPI partnership

BioNTech is in the midst of conducting clinical trials for its mRNA-based mpox v...

Risk adjusted net present value: What is the current va...

MK-0616 is a peptide commercialized by Merck, with a leading Phase III program i...

Kinnate Biopharma announces 70% layoffs and pipeline re...

The company will suspend the development of three assets, considering strategic ...

Overcoming disruptions in the pharmaceutical supply chain 

We interviewed Datwyler’s Gabrielle Gehron to understand the best sourcing strat...

Otsuka and Astex’s oral Inaqovi wins European approval ...

European Commission has approved the oral combination drug for treating newly di...

60 Degrees pauses Phase IIB Covid-19 trial for tafenoquine

The company plans to refile the IND after assessing the feasibility of US FDA-su...

Pelican and Primordial Genetics merge to form biotech c...

Pelican Technology has combined business with Primordial Genetics under a deal t...

Orexo announces NDA submission to FDA for opioid overdo...

Orexo has submitted a new drug application (NDA) to the US FDA for its high-dose...

BioNTech and CEPI partner to develop Mpox vaccine

BioNTech has entered a strategic collaboration with the CEPI to develop mRNA-bas...

Pharmanovia announces acquisition of Sanofi’s CNS brands

UK-based Pharmanovia has announced the acquisition of 11 central nervous system ...

Risk adjusted net present value: What is the current va...

Puxitatug Samrotecan is a monoclonal antibody conjugated commercialized by Astra...

STAT+: Patients, doctors press FTC to beef up hospital ...

The FTC and DOJ got a flood of comments urging them to adopt their proposed merg...

STAT+: Pharmalittle: U.S. Chamber and feds clash on Med...

Chamber and government lawyers sparred over whether drugmakers have enough say i...